Close Menu

Columbia

This Week in Nature

In Nature this week: CRISPR-Cas9 genome editing system that does not require double-strand DNA breaks, and more.

This Week in Science

In Science this week: somatic mutations found throughout normal tissue, and more.

The Columbia Solid Tumor Panel, a custom NGS panel from Pillar Biosciences, will be used at CUMC's Laboratory of Personalized Genomic Medicine.

A LIMS1 gene variant appeared to coincide with increased risk of allograft rejection in kidney transplant recipients.

Consumer genomics companies have endeavored to reach out to minority communities with sometimes contentious results.

This Week in PNAS

In PNAS this week: core Pseudomonas aeruginosa genome, study of ancient Paget's disease of the bone, and more.

This Week in Nature

In Nature this week: genomic factors that influence glioblastoma response to anti-PD-1 therapy, sequencing test for infectious disease, and more.

For Smarts?

A trio of researchers writes at Stat News that while editing embryos to improve IQ is not yet possible, there's already a way to predict which embryos might be the smartest.

Researchers identified PTEN mutations, MAP kinase pathway alterations, and other features linked to anti-PD-1 response in individuals with the brain cancer.

Basic Editing

NPR reports on ongoing basic research involving CRISPR and human embryos in the US.

Pages

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.